What the numbers say: According to Mercom Capital,
global venture capital (VC) funding
in Digital Health, including private equity and corporate VC, came to $14.8B in 637 deals, a 66% increase compared to $8.9B in 615 deals during 2019. Total corporate funding for digital health companies,
including VC, debt, and public market financing, reached $21.6B in 2020.
Relevance: In 2022, the
global digital health market
was valued at approximately $262.63B billion, projected to reach around 939.54B by 2032, exhibiting a compound annual growth rate (CAGR) of 13.1% during the forecast period from 2023 to 2032. According to
Precedence Research, the U.S. digital health market accounted for $56.86B in 2022.
Brands that should care: Amid the pandemic, a substantial portion of available funding was utilized to support startups, but only a limited number in the biotech and healthtech industries
successfully reached the IPO stage. According to Refinitiv data, the biotech sector witnessed 152 offerings in 2021, generating over $25B in funds. However, this figure drastically declined to 47 IPOs the
following year, raising approximately $4B.